Gulla SK - Search Results

1

Biodistribution and therapeutic efficacy of a gold nanoparticle-based targeted drug delivery system against pancreatic cancer.

Elechalawar CK, Gulla SK, Roy RV, Means N, Zhang Y, Asifa S, Robertson DJ, Xu C, Bhattacharya R, Mukherjee P. Elechalawar CK, et al. Among authors: gulla sk. Cancer Lett. 2024 May 1;589:216810. doi: 10.1016/j.canlet.2024.216810. Epub 2024 Mar 15. Cancer Lett. 2024. PMID: 38494151

2

Gold Nanoparticles Disrupt the IGFBP2/mTOR/PTEN Axis to Inhibit Ovarian Cancer Growth.

Hossen MN, Wang L, Dwivedi SKD, Zhang Y, Rao G, Elechalwar CK, Sheth V, Dey A, Asfa S, Gulla SK, Xu C, Fung KM, Robertson JD, Bieniasz M, Wilhelm S, Bhattacharya R, Mukherjee P. Hossen MN, et al. Among authors: gulla sk. Adv Sci (Weinh). 2022 Nov;9(31):e2200491. doi: 10.1002/advs.202200491. Epub 2022 Sep 14. Adv Sci (Weinh). 2022. PMID: 36104215 Free PMC article.

3

Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation.

Elechalawar CK, Rao G, Gulla SK, Patel MM, Frickenstein A, Means N, Roy RV, Tsiokas L, Asfa S, Panja P, Rao C, Wilhelm S, Bhattacharya R, Mukherjee P. Elechalawar CK, et al. Among authors: gulla sk. ACS Nano. 2023 May 23;17(10):9326-9337. doi: 10.1021/acsnano.3c00920. Epub 2023 May 2. ACS Nano. 2023. PMID: 37129853 Free PMC article.

4

Correction to "Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation".

Elechalawar CK, Rao G, Gulla SK, Patel MM, Frickenstein A, Means N, Roy RV, Tsiokas L, Asfa S, Panja P, Rao C, Wilhelm S, Bhattacharya R, Mukherjee P. Elechalawar CK, et al. Among authors: gulla sk. ACS Nano. 2024 Mar 26;18(12):9242. doi: 10.1021/acsnano.4c01293. Epub 2024 Mar 11. ACS Nano. 2024. PMID: 38465974 No abstract available.

5

In vivo Targeting of DNA Vaccines to Dendritic Cells via the Mannose Receptor Induces Long-Lasting Immunity against Melanoma.

Moku G, Vangala S, Gulla SK, Yakati V. Moku G, et al. Among authors: gulla sk. Chembiochem. 2021 Feb 2;22(3):523-531. doi: 10.1002/cbic.202000364. Epub 2020 Oct 26. Chembiochem. 2021. PMID: 32909670

6

Au-CGKRK Nanoconjugates for Combating Cancer through T-Cell-Driven Therapeutic RNA Interference.

Gulla SK, Kotcherlakota R, Nimushakavi S, Nimmu NV, Khalid S, Patra CR, Chaudhuri A. Gulla SK, et al. ACS Omega. 2018 Aug 3;3(8):8663-8676. doi: 10.1021/acsomega.8b01051. eCollection 2018 Aug 31. ACS Omega. 2018. PMID: 31458997 Free PMC article.

7

In vivo targeting of DNA vaccines to dendritic cells using functionalized gold nanoparticles.

Gulla SK , Rao BR , Moku G , Jinka S , Nimmu NV , Khalid S , Patra CR , Chaudhuri A . Gulla SK , et al. Biomater Sci. 2019 Feb 26;7(3):773-788. doi: 10.1039/c8bm01272e. Biomater Sci. 2019. PMID: 30601510

8

Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes.

Moku G, Gulla SK, Nimmu NV, Khalid S, Chaudhuri A. Moku G, et al. Among authors: gulla sk. Biomater Sci. 2016 Apr;4(4):627-38. doi: 10.1039/c5bm00479a. Epub 2016 Jan 25. Biomater Sci. 2016. PMID: 26806172

9

Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response.

Garu A, Moku G, Gulla SK, Chaudhuri A. Garu A, et al. Among authors: gulla sk. Mol Ther. 2016 Feb;24(2):385-397. doi: 10.1038/mt.2015.215. Epub 2015 Dec 15. Mol Ther. 2016. PMID: 26666450 Free PMC article.

10

Examples of Tumor Growth Inhibition Properties of Liposomal Formulations of pH-Sensitive Histidinylated Cationic Amphiphiles.

Garu A, Moku G, Gulla SK, Pramanik D, Majeti BK, Karmali PP, Shaik H, Sreedhar B, Chaudhuri A. Garu A, et al. Among authors: gulla sk. ACS Biomater Sci Eng. 2015 Aug 10;1(8):646-655. doi: 10.1021/acsbiomaterials.5b00025. Epub 2015 Jul 23. ACS Biomater Sci Eng. 2015. PMID: 33435088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page